Sequent Scientific Limited, now operating as Viyash Scientific Limited, has rescheduled its quarterly earnings conference call to discuss Q3FY26 financial results. The company notified stock exchanges about this scheduling update through a regulatory filing dated February 03, 2026.

Rescheduled Conference Call Details

The earnings call has been moved to a new date and time to accommodate stakeholder participation:

Management Participation

The conference call will feature key members of the senior management team who will interact with analysts and investors:

• Dr. Hari Babu Bodepudi - Managing Director & Group CEO
• Mr. Rajaram Narayanan - Executive Director and CEO – Animal Health
• Mr. Ramakant Singani - Chief Financial Officer

Access Information

Participants can join the earnings call through multiple access options:

Regulatory Compliance

The rescheduling notification was submitted to both major Indian stock exchanges as required under regulatory guidelines. Yoshita Vora, Company Secretary & Compliance Officer, signed the official communication that was sent to BSE Limited and National Stock Exchange of India Limited. The company trades under scrip code 512529 on BSE and symbol SEQUENT on NSE.

Investors and analysts interested in participating can access complete conference call details and registration information on the company's official website at www.sequent.in in the Investors section.

Viyash Scientific Limited (formerly known as Sequent Scientific Limited) has completed the allotment of 4,83,333 equity shares under its Employee Stock Option Plan 2020 scheme. The company informed stock exchanges about this development through a regulatory filing dated January 29, 2026.

ESOP Allotment Details

The Nomination and Remuneration Committee approved the allotment through a resolution passed by circulation on January 29, 2026. The shares were issued to eligible employees under the SeQuent ESOP 2020 scheme.

Impact on Share Capital

The allotment has resulted in an increase in the company's issued and paid-up equity share capital. The newly allotted shares will rank pari passu in all respects with the existing equity shares of the company.

Corporate Information

Viyash Scientific Limited, formerly known as Sequent Scientific Limited, is headquartered in Hyderabad, Telangana. The company trades on both BSE and NSE with scrip code 512529 and symbol VIYASH respectively. The regulatory filing was signed by Yoshita Vora, Company Secretary and Compliance Officer, confirming the completion of the ESOP allotment process.

The company has requested both stock exchanges to take note of this allotment and update their records accordingly. This ESOP allotment represents part of the company's employee incentive program designed to align employee interests with shareholder value creation.